Back to search

Article

Antibody-Drug Conjugates for Breast Cancer: A Bibliometric Study and Clinical Trial Analysis

2024-05-07

Abstract excerpt

<title>Abstract</title> <p>Background Breast cancer (BC) remains the most commonly diagnosed malignancy among women globally. Although early-stage BC typically presents with curative possibilities, advanced-stage disease, especially when complicated by metastatic involvement, is significantly limited in terms of efficacious therapeutic interventions, thereby establishing it as the second leading cause of cancer-...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
569e38c0-62fa-59ea-b5c9-c4e6804ba7dc
DOI
10.21203/rs.3.rs-4243080/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Antibody-Drug Conjugates for Breast Cancer: A Bibliometric Study and Clinical Trial AnalysisDOI 10.21203/rs.3.rs-4243080/v1
Research on therapeutic clinical trials including immunotherapy in Triple- negative Breast cancer: A bibliometric analysisSemantic proximity
Clinical Potential of Antibody–Drug Conjugates in Early-Phase Clinical Trials for Late-Line Treatment of Advanced Solid TumorsSemantic proximity
Research Progress of Natural Drugs for Breast Cancer in the Past 30 Years Based on Bibliometric and Knowledge Graph AnalysisSemantic proximity
The Efficacy and Safety of Sacituzumab Govitecan in Heavily Pretreated Metastatic Triple-Negative and Hormone Receptor-Positive/HER2-Negative Breast Cancer: A Multicenter Real-World Study from TurkeySemantic proximity
Identification of cell surface targets for CAR-T cell therapies and antibody–drug conjugates in breast cancerSemantic proximity
Exploring the therapeutic use and outcome of antibody-drug conjugates in ovarian cancer treatmentSemantic proximity
Frontiers and hotspots in induction chemotherapy of oral squamous cell carcinoma: a bibliometric and visualized study from 2000 to 2022 by Bioinformatics and Cancer Database AnalysisSemantic proximity
Expanding the repertoire of Antibody Drug Conjugate (ADC) targets with improved tumor selectivity and range of potent payloads through in-silico analysis.Semantic proximity
From Small Molecules to Degraders and AI: Contemporary Trends and Future Directions in Anticancer Drug DiscoverySemantic proximity
From Small Molecules to Degraders and AI: Contemporary Trends and Future Directions in Anticancer Drug DiscoverySemantic proximity
Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistanceSemantic proximity
Real-world data of eribulin in advanced and pretreated HER2-negative breast cancer in a Spanish comprehensive cancer centerSemantic proximity
Select a neighboring publication to make it the new centre.